What Does Morphic Therapeutic Do?

Total employees71
HeadquartersWaltham
Founded2015

Morphic Therapeutic (NASDAQ: MORF) is a clinical-stage biopharmaceutical company applying its proprietary MInT (Morphic Integrin Technology) Platform to develop a new generation of oral integrin therapies. Integrins are cell surface receptors crucial for cell adhesion and signaling; their dysregulation is implicated in various serious chronic diseases. Morphic aims to discover and develop highly selective, orally-bioavailable small molecule modulators of integrins to treat conditions such as autoimmune disorders (like ulcerative colitis and Crohn's disease), fibrosis, and NASH (non-alcoholic steatohepatitis). Their innovative approach seeks to overcome historical limitations of integrin-targeted therapies, focusing on oral administration and improved therapeutic profiles.

Where Is Morphic Therapeutic's Headquarters?

HQ Function

Serves as the primary center for the company's research and development efforts, clinical operations leadership, corporate strategy, and general administrative functions.

Notable Features:

The headquarters comprises modern laboratory and office spaces designed to support cutting-edge scientific research and collaboration. It is situated within a life sciences campus environment.

Work Culture:

Morphic fosters a science-driven, innovative, and collaborative work culture. Employees are typically focused on advancing novel therapeutics with a strong emphasis on teamwork, scientific rigor, and addressing unmet patient needs.

HQ Significance:

The Waltham headquarters is pivotal for driving Morphic's pipeline of oral integrin therapeutics, from initial discovery through clinical development stages, and for managing the company's strategic growth and operations.

Values Reflected in HQ: The headquarters' location and facilities reflect Morphic's commitment to scientific excellence, innovation, collaboration, and its position within a leading global biotechnology hub.

Location:

Morphic Therapeutic is headquartered in the United States. While its primary research and corporate functions are centralized, the company's clinical trial activities for its therapeutic candidates, such as MORF-057, often involve multiple sites and patient populations internationally. Its business development and potential commercialization strategies also maintain a global outlook to reach patients worldwide.

Street Address:

35 Gatehouse Drive, Building A

City:

Waltham

State/Province:

MA

Country:

USA

Where Else Does Morphic Therapeutic Operate Around the World?

No additional office locations available.

Buying Intent Signals for Morphic Therapeutic

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Morphic Therapeutic? Meet the Executive Team

As of April 2025, Morphic Therapeutic' leadership includes:

Praveen P. Tipirneni, M.D. - President, Chief Executive Officer and Director
Marc Schegerin, M.D. - Chief Financial Officer and Chief Operating Officer
Bruce Rogers, Ph.D. - Chief Scientific Officer
Peter Linde, M.D. - Chief Medical Officer
Joanne M. Donovan, M.D., Ph.D. - Chief Development Officer
Alexey Eletsky, Ph.D. - Chief Business Officer

Who's Investing in Morphic Therapeutic?

Morphic Therapeutic has been backed by several prominent investors over the years, including:

SR One
Omega Funds
Polaris Partners
AbbVie Ventures
Pfizer Ventures
EcoR1 Capital
OrbiMed
Fidelity Management & Research Company
The Vanguard Group
BlackRock
Wellington Management

What Leadership Changes Has Morphic Therapeutic Seen Recently?

Hire1
Exits1

Over the last 12 months, Morphic Therapeutic notably strengthened its executive leadership by appointing a new Chief Business Officer to drive corporate strategy and business development initiatives.

Departures

Blaise Li, Ph.D., Blaise Li, Ph.D., departed from his role as Chief Business Officer.

New Appointments:

Alexey Eletsky, Ph.D., Alexey Eletsky, Ph.D., was appointed as the new Chief Business Officer to lead Morphic's business development and corporate strategy efforts.

What Technology (Tech Stack) Is Used byMorphic Therapeutic?

Discover the tools Morphic Therapeutic uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Morphic Therapeutic Email Formats and Examples

Morphic Therapeutic most commonly uses the email format combining the first initial of an employee's name with their full last name. This is a standard convention in many biotechnology and pharmaceutical companies.

flast@morphictx.com

Format

jdoe@morphictx.com

Example

85%

Success rate

What's the Latest News About Morphic Therapeutic?

Morphic Therapeutic IRMay 8, 2024

Morphic Therapeutic Reports First Quarter 2024 Financial Results and Provides Corporate Update

Morphic Therapeutic announced its Q1 2024 financial results, highlighting progress in its clinical programs, particularly MORF-057 for ulcerative colitis and Crohn's disease. The company also provided updates on its cash runway and upcoming milestones....more

Morphic Therapeutic IRMarch 4, 2024

Morphic Therapeutic Appoints Alexey Eletsky, Ph.D. as Chief Business Officer

Morphic announced the strategic appointment of Alexey Eletsky, Ph.D., as its new Chief Business Officer. Dr. Eletsky brings significant biopharma industry experience to lead Morphic's business development and corporate strategy....more

Morphic Therapeutic IRJanuary 4, 2024

Morphic Therapeutic Provides 2024 Corporate Outlook Highlighting Key Development Milestones for MORF-057 and Pipeline Expansion

Morphic outlined its strategic priorities and anticipated milestones for 2024, focusing on the advancement of MORF-057 through Phase 2b studies (EMERALD-1 and EMERALD-2) and the continued development of its broader pipeline of oral integrin candidates....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Morphic Therapeutic, are just a search away.